Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record now displays details and results for the pembrolizumab trial, including outcome measures, treatment compliance, study dates, and a study protocol document. It also provides the trial’s eligibility criteria, locations, and participating organizations.
    Difference
    49%
    Check dated 2026-11-10T07:28:53.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.2 to v3.8.0 on the otherwise unchanged 403 error page.
    Difference
    0.2%
    Check dated 2026-11-03T10:25:23.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T10:28:57.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T10:10:19.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The study page now displays a 403 error, replacing the usual content with an error message. This indicates an access-control issue that prevents retrieving trial details from the page.
    Difference
    18%
    Check dated 2026-09-22T12:22:30.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The revision label updated from v3.6.5 to v3.6.6. This indicates a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-08-31T23:31:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.